marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q3
added 11-12-2024
Voyager Therapeutics Cash Flow 2011-2024 | VYGR
Annual Cash Flow Voyager Therapeutics
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
77.9 M | -12.5 M | -53.5 M | -96.7 M | 48.7 M | -15.9 M | -61.4 M | -42.5 M | 41.3 M | - | - | - | - |
Depreciation & Amortization |
4.44 M | 6.19 M | 5.16 M | 3.82 M | 2.76 M | 2.12 M | 1.6 M | 612 K | 600 K | 184 K | - | - | - |
Accounts Payables |
1.6 M | 2.57 M | 574 K | 634 K | 4.07 M | 1.04 M | 1.02 M | 550 K | 612 K | - | - | - | - |
Accounts Receivables |
80.2 M | 382 K | 16 K | 95 K | 203 K | 201 K | 122 K | 339 K | 411 K | - | - | - | - |
Total Inventories |
- | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Cash Flow Voyager Therapeutics
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
- | - | 58.8 M | - | - | - | 124 M | - | -265 K | - | 34.4 M | - | -64.7 M | - | -21.3 M | - | -74.7 M | -50 M | -28.8 M | - | 72 M | 93.6 M | 125 M | - | 8.46 M | 26.1 M | 48.6 M | - | -46.5 M | -30.6 M | -14.3 M | - | -29.4 M | -19.2 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Depreciation & Amortization |
- | - | 1.2 M | - | - | - | 1.08 M | - | 5.36 M | - | 2.81 M | - | 3.68 M | - | 1.27 M | - | 2.83 M | 1.77 M | 842 K | - | 2.01 M | 1.29 M | 616 K | - | 1.54 M | 972 K | 456 K | - | 1.16 M | 726 K | 317 K | - | 448 K | 288 K | 136 K | - | 63 K | 276 K | 131 K | - | 160 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Accounts Payables |
3.16 M | 2.6 M | 7.58 M | 1.6 M | 3.27 M | 1.66 M | 3.7 M | 2.57 M | 1.34 M | - | 1.2 M | 574 K | 592 K | 790 K | 3.18 M | 634 K | 634 K | 634 K | 634 K | 4.07 M | 4.07 M | 4.07 M | 4.07 M | 1.04 M | 1.04 M | 1.04 M | 1.04 M | 1.02 M | 1.02 M | 1.02 M | 1.02 M | 550 K | 550 K | 550 K | 550 K | 612 K | 612 K | 612 K | 612 K | 1.55 M | 1.55 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Accounts Receivables |
16 M | 1.7 M | 837 K | 80.2 M | - | - | 25 M | - | 10 M | - | - | 16 K | - | - | - | 95 K | - | - | - | 476 K | - | - | - | 617 K | - | - | - | 122 K | - | - | - | 339 K | - | - | - | 411 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Inventories |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency